T 0676/21 (Pharmaceutical dosage form for immediate release of an indolinone derivative / BOEHRINGER INGELHEIM) of 15.06.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T067621.20230615
- Date of decision
- 15 June 2023
- Case number
- T 0676/21
- Petition for review of
- -
- Application number
- 09757601.1
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PHARMACEUTICAL DOSAGE FORM FOR IMMEDIATE RELEASE OF AN INDOLINONE DERIVATIVE
- Applicant name
- Boehringer Ingelheim International GmbH
- Opponent name
- Teva Pharmaceutical Industries Ltd.
Generics (U.K.) Limited
Ter Meer Steinmeister & Partner Patentanwälte mbB - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Amendment after summons - exceptional circumstances (yes)
Amendments - allowable (yes)
Sufficiency of disclosure - (yes)
Inventive step - (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The decision under appeal is set aside.
The case is remitted to the opposition division with the order to maintain the patent on the basis of auxiliary request 1 filed during the oral proceedings on 15 June 2023.